What have we learnt?
The two-day, information-packed agenda examined key market drivers and trends in healthcare and life sciences investing.
We have addressed the top performing subsectors, examine the regulatory landscape and explored the future outlook.
The attendees learnt about the evolution of investment strategies and got practical insight into delivering value and returns by investing in this lucrative space.
Who have we learnt from?
50+ specialist speakers advising on the best investment strategies and business models.
We heard from market leading investors, including sector-focused and generalist venture capital and private equity fund managers, advisors and healthcare and life sciences investment experts.
Who did you meet?
The international healthcare and life sciences investment community, including GPs, LPs, investment consultants and service providers.
Plus many promising start-ups, representatives from medical device companies, technology and healthcare IT firms.